Risedronate Sodium
NDC 60723-041, Risedronate Sodium, tablet, film coated, from Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd.
- Product NDC
- 60723-041
- Status
- Listed
- Labeler
- Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207516
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60723-041 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RISEDRONATE SODIUM HEMI-PENTAHYDRATE35 mg/1
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60723-041-04 | 60723004104 | 1 BLISTER PACK in 1 CARTON (60723-041-04) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01) |
| 60723-041-12 | 60723004112 | 3 BLISTER PACK in 1 CARTON (60723-041-12) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d60a56cb-ef49-4447-9043-7b6879a20d75
Use it
Look up 60723-041 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60723-041 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60723-041. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.